How much funding has Senseonics raised?

Senseonics has raised $100.0M in total funding, most recently a Series A round.

Who are Senseonics's investors?

Senseonics's investors include Hercules Capital, Abbott Laboratories.

When was Senseonics founded?

Senseonics was founded in 1996.

Where is Senseonics headquartered?

Senseonics is headquartered in Germantown, Maryland, United States.

What industry is Senseonics in?

Senseonics operates in healthcare, Healthcare, medical devices, Medical Devices, Wearables.

How many employees does Senseonics have?

Senseonics has 51-200 employees.

Senseonics

IPO

Creators of the first and only Long-term Implantable CGM.

Public · Germantown, United States · Founded 1996 · $100.0M raised

Headquarters: Germantown, Maryland
Employees: 51–200
Founded: 1996
Business Model: B2C
Website: senseonics.com

Total Funding: $100.0M
Last Round: $20.0M Series AJun 2026
Rounds: 2
Type: Public

About

Senseonics is a publicly traded medical technology company (NYSE: SENS) that develops the Eversense continuous glucose monitoring (CGM) system—the world's first and only long-term implantable CGM for people with diabetes. The Eversense 365 sensor is implanted under the skin and lasts up to 365 days, using fluorescence-based sensing technology paired with a removable smart transmitter and mobile app.

Summary

Senseonics is a healthcare company based in Germantown, United States, founded in 1996. It has raised $100.0M in total across 2 rounds, most recently a $20.0M Series A round in Jun 2026. Investors include Hercules Capital and Abbott Laboratories.

LinkedIn X (Twitter)